Fig. 7From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approacha Pre-NAC mammogram; sSpiculated UOQ and UIQ masses. b Post-NAC mammogram; mild reduction mild reduction in size. c Pre-NAC CESM; grouped lesions. d Post-NAC CESM; type III shrinkage. RECIST 1.1; non-responder. Combined response evaluation; partial responder. Pathology; Miller-Payne grade 3Back to article page